A
Aion Therapeutic Inc
CNSX:AION
Aion Therapeutic Inc
CNSX:AION
Price:
0.005
CAD
Market Closed
Market Cap:
CA$2.4m
Balance Sheet
Balance Sheet Decomposition
Aion Therapeutic Inc
Aion Therapeutic Inc
Balance Sheet Decomposition is not available for
Aion Therapeutic Inc
Aion Therapeutic Inc
Balance Sheet
Aion Therapeutic Inc
Aion Therapeutic Inc
Currency: CAD
| Apr-2014 | Apr-2015 | Apr-2016 | Apr-2017 | Apr-2018 | Apr-2019 | Apr-2020 | Apr-2021 | Apr-2022 | Apr-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
2
|
1
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
2
|
1
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
0
|
0
|
0
|
0
|
2
|
1
|
0
|
0
|
0
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
2
|
3
|
1
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
0
N/A
|
0
N/A
|
0
-75%
|
0
-50%
|
4
+41 000%
|
3
-19%
|
2
-52%
|
0
-91%
|
0
+40%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
3
|
3
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
+16%
|
1
+42%
|
0
-53%
|
0
+33%
|
1
+359%
|
1
-18%
|
1
+1%
|
3
+112%
|
3
+15%
|
|
| Equity | |||||||||||
| Common Stock |
2
|
2
|
2
|
3
|
3
|
8
|
8
|
13
|
15
|
15
|
|
| Retained Earnings |
2
|
2
|
2
|
4
|
4
|
6
|
7
|
15
|
19
|
19
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
1
|
|
| Total Equity |
0
N/A
|
0
-17%
|
0
-23%
|
0
+49%
|
0
-41%
|
3
N/A
|
2
-19%
|
0
-81%
|
2
N/A
|
3
-13%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
N/A
|
0
N/A
|
0
-75%
|
0
-50%
|
4
+41 000%
|
3
-19%
|
2
-52%
|
0
-91%
|
0
+40%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
22
|
22
|
22
|
16
|
16
|
35
|
37
|
125
|
142
|
147
|
|
Switch to:
Switch to:
See Also
Discover More
